958 related articles for article (PubMed ID: 15804727)
21. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
Langer RD
Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
[TBL] [Abstract][Full Text] [Related]
22. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
23. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
[TBL] [Abstract][Full Text] [Related]
24. Current trends in hormone replacement therapy.
Khashoggi TY
Saudi Med J; 2002 May; 23(5):495-502. PubMed ID: 12070567
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
26. Estrogen with and without progestin: benefits and risks of short-term use.
LaCroix AZ
Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
[TBL] [Abstract][Full Text] [Related]
27. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
Stefanick ML
Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
[TBL] [Abstract][Full Text] [Related]
28. Menopausal hormone therapy: currently no evidence for cardiac protection.
Wenger NK
Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
[TBL] [Abstract][Full Text] [Related]
29. Estrogen, progestogens and cardiovascular risk.
Stefanick ML
J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
[TBL] [Abstract][Full Text] [Related]
30. Hormone therapy and coronary heart disease in young women.
Weiner MG; Barnhart K; Xie D; Tannen RL
Menopause; 2008; 15(1):86-93. PubMed ID: 17502840
[TBL] [Abstract][Full Text] [Related]
31. The new conundrum: do estrogens have any cardiovascular benefits?
Clarkson TB
Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
[TBL] [Abstract][Full Text] [Related]
32. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
[TBL] [Abstract][Full Text] [Related]
33. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
Manson JE; Bassuk SS
Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
35. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy.
Antonicelli R; Olivieri F; Morichi V; Urbani E; Mais V
Int J Cardiol; 2008 Nov; 130(2):140-6. PubMed ID: 18617278
[TBL] [Abstract][Full Text] [Related]
36. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
Tan O; Harman SM; Naftolin F
Bull NYU Hosp Jt Dis; 2009; 67(2):226-9. PubMed ID: 19583558
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
Robinson JG; Wallace R; Limacher M; Ren H; Cochrane B; Wassertheil-Smoller S; Ockene JK; Blanchette PL; Ko MG
Am J Cardiol; 2008 Sep; 102(6):693-9. PubMed ID: 18773990
[TBL] [Abstract][Full Text] [Related]
38. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
[TBL] [Abstract][Full Text] [Related]
39. Menopause: evidence-based practice.
Blake J
Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):799-839. PubMed ID: 17084674
[TBL] [Abstract][Full Text] [Related]
40. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
